- Home
- » Tags
- » Receptor antagonist
Top View
- Absorption, Metabolism, and Excretion of the Antiemetic Rolapitant, a Selective Neurokinin-1 Receptor Antagonist, in Healthy Male Subjects
- The Competitive NMDA Receptor Antagonist CPP Disrupts Cocaine-Induced Conditioned Place Preference, but Spares Behavioral Sensitization
- Role of MRP1 in Multidrug Resistance in Acute Myeloid Leukemia O Legrand, R Zittoun and J-P Marie
- List Item Acomplia : EPAR
- Serotonin Receptors and Drugs Affecting Serotonergic Neurotransmission R ICHARD A
- Journal of Psychopharmacology
- Selective Kappa-Opioid Antagonism Ameliorates Anhedonic Behavior: Evidence from the Fast-Fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)
- Acute Toxicity and Neurobehavioral Effects of Diphenhydramine in Chicks
- The Selective Serotonin-2A Receptor Antagonist M100907 Reverses Behavioral Deficits in Dopamine Transporter Knockout Mice
- Tumor Immunotherapy Using A2A Adenosine Receptor Antagonists
- Structure-Based Discovery of Selective Positive Allosteric Modulators Of
- Fevipiprant, an Oral Prostaglandin DP2 Receptor (Crth2) Antagonist, in Allergic Asthma Uncontrolled on Low-Dose Inhaled Corticosteroids
- Molecular Modeling of Histamine Receptors—Recent Advances in Drug Discovery
- 5-HT Receptors and the Development of New Antidepressants
- Current Concepts and Treatments of Schizophrenia
- Inhibition of the MRP1-Mediated Transport of the Menadione
- Novel Selective Cannabinoid CB1 Receptor Antagonist MJ08 with Potent in Vivo Bioactivity and Inverse Agonistic Effects
- Neuroscience-Based Nomenclature (Nbn) for Journal of Psychopharmacology
- 5-HT Receptors and Their Ligands, Tocris Reviews No
- Clinical Pharmacokinetics of Angiotensin II (AT1) Receptor Blockers in Hypertension
- Leukotriene Receptor Antagonist Therapy
- Critical Review of KETAMINE
- Receptor Antagonist Optimized for High Potency in Adenosine-Rich Tumor
- Year Medical Student Psychopharmacology Class Sheryl B
- Increased Neurokinin-1 Receptor Availability in the Amygdala in Social Anxiety Disorder: a Positron Emission Tomography Study with [11C]GR205171
- Ketamine: Promising Path Or False Prophecy in the Development of Novel Therapeutics for Mood Disorders&Quest;
- Angiotensin II Receptor Antagonists Role in Arterial Hypertension
- Pharmacology and Clinical Activity of Toreforant, a Histamine H4
- Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
- Prognostic Significance of Multidrug Resistance Protein in Adult T-Cell Leukemia1
- Lessons from the A2A Adenosine Receptor Antagonist– Enabled Tumor Regression and Survival in Patients with Treatment-Refractory Renal Cell Cancer Michail V
- Introduction to Pharmacokinetics and Pharmacodynamics
- Focusing on Adenosine Receptors As a Potential Targeted Therapy in Human Diseases
- Structure-Based Development of a Subtype-Selective Orexin 1 Receptor Antagonist
- Pharmacology Dynamics Kinetics Genetics Dr Lindsey Ferrie [email protected]
- Thromboxane Receptors Antagonists And/Or Synthase Inhibitors
- 211243Orig1s000